Accordingly, the biomarkers Total-Tau (T-Tau) and amyloid-β 1–42 were previously hypothesised to aid in differentiating between Alzheimer’s disease and iNPH [37, 38]. The gene discussed is MAPT; the disease is Alzheimer disease.